托珠单抗准备推出白细胞介素-6抑制剂。 - Suppr

Actemra poised to launch IL-6 inhibitors.

作者信息

Melton Lisa, Coombs Amy

出版信息

Nat Biotechnol. 2008 Sep;26(9):957-9. doi: 10.1038/nbt0908-957.

DOI:10.1038/nbt0908-957

PMID:18779787

Abstract

摘要

相似文献

Actemra poised to launch IL-6 inhibitors.

Nat Biotechnol. 2008 Sep;26(9):957-9. doi: 10.1038/nbt0908-957.

Nat Biotechnol. 2008 Sep;26(9):985-90. doi: 10.1038/nbt0908-985.

Flexibility--the guiding principle for antibody manufacturing.

Nat Biotechnol. 2005 Sep;23(9):1054-8. doi: 10.1038/nbt0905-1054.

Monoclonal antibody successes in the clinic.

Nat Biotechnol. 2005 Sep;23(9):1073-8. doi: 10.1038/nbt0905-1073.

High throughput screening: early successes indicate a promising future.

J Biomol Screen. 2001 Jun;6(3):137-40. doi: 10.1177/108705710100600303.

Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.

Crit Care Med. 2003 May;31(5):1495-501. doi: 10.1097/01.CCM.0000065725.80882.BD.

Greg Winter.

Nat Biotechnol. 2011 Mar;29(3):190. doi: 10.1038/nbt.1815.

Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery.

Drug Discov Today. 2007 Oct;12(19-20):789-93. doi: 10.1016/j.drudis.2007.09.002.

Sequence-based protein kinase inhibition: applications for drug development.

Biotechniques. 2005 Oct;39(4):575-6.

Humanized antihuman IL-6 receptor antibody, tocilizumab.

Handb Exp Pharmacol. 2008(181):151-60. doi: 10.1007/978-3-540-73259-4_7.

引用本文的文献

Desensitization in HLA-incompatible kidney transplant recipients: current strategies and emerging perspectives.

Clin Kidney J. 2025 Jul 9;18(8):sfaf219. doi: 10.1093/ckj/sfaf219. eCollection 2025 Aug.

Current stage in inflammatory bowel disease: What is next?

World J Gastroenterol. 2015 Oct 28;21(40):11282-303. doi: 10.3748/wjg.v21.i40.11282.

Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis.

Clin Ophthalmol. 2014 Jan 8;8:187-90. doi: 10.2147/OPTH.S54929. eCollection 2014.

Plasmacytoid dendritic cell-derived IFN-α promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1.

Hepatology. 2014 Jul;60(1):267-77. doi: 10.1002/hep.27037. Epub 2014 May 27.

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Lancet. 2012 Mar 31;379(9822):1214-24. doi: 10.1016/S0140-6736(12)60110-X. Epub 2012 Mar 14.

Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.

J Biol Chem. 2011 Dec 16;286(50):42959-70. doi: 10.1074/jbc.M111.295758. Epub 2011 Oct 11.

Genetic evidence for an essential role of neuronally expressed IL-6 signal transducer gp130 in the induction and maintenance of experimentally induced mechanical hypersensitivity in vivo and in vitro.

Mol Pain. 2011 Sep 27;7:73. doi: 10.1186/1744-8069-7-73.

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

J Clin Invest. 2011 Sep;121(9):3375-83. doi: 10.1172/JCI57158. Epub 2011 Sep 1.

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.

Cancer Manag Res. 2011;3:177-89. doi: 10.2147/CMR.S18101. Epub 2011 May 18.

Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.

J Cell Mol Med. 2011 Mar;15(3):484-500. doi: 10.1111/j.1582-4934.2010.01245.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Actemra poised to launch IL-6 inhibitors.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献